{"id":"yiqifang","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal side effects"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of YiQiFang is not fully understood, but it is believed to work by modulating the immune system and reducing inflammation. This is thought to be achieved through the regulation of various signaling pathways and the modulation of immune cell function.","oneSentence":"YiQiFang is a traditional Chinese medicine that has been shown to have anti-inflammatory and immunomodulatory effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:41:17.238Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT02900742","phase":"PHASE3","title":"Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2013-03","conditions":"Cancer","enrollment":71},{"nctId":"NCT02889692","phase":"PHASE3","title":"Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2013-03","conditions":"Cancer","enrollment":23},{"nctId":"NCT01780181","phase":"","title":"Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2012-12","conditions":"Cancer","enrollment":82},{"nctId":"NCT01745302","phase":"","title":"Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma","status":"UNKNOWN","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2011-11","conditions":"Cancer","enrollment":470}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"YiQiFang","genericName":"YiQiFang","companyName":"Shanghai University of Traditional Chinese Medicine","companyId":"shanghai-university-of-traditional-chinese-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"YiQiFang is a traditional Chinese medicine that has been shown to have anti-inflammatory and immunomodulatory effects. Used for Treatment of rheumatoid arthritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}